Companies · Healthtech

Fruit Street Health, P.B.C.

Fort Worth · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Fruit Street Health, P.B.C. — recommendation, valuation, rhythm, risks.
$60.9M
Total raised · real
6
Rounds
0.0×
Latest step-up
Top 9%
Sector rank · raised
Series B
Latest stage · inferred · Wed Jan 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Fruit Street Health, P.B.C. looks under-valued against its niche peers and is quiet on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.01× the median modeled value of Series B Healthtech companies in 2025–2027 (55 peers) — value vs value, same stage and era.
  • Issuer reports $0–$1M revenue while modeled below niche peers.
Quiet
  • Last raise 18 mo ago; this sector typically re-raises about every 14 months.
  • Slightly overdue versus sector cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Fruit Street Health, P.B.C. is one of 2138 Healthtech companies tracked from Fort Worth. By capital raised it ranks among the largest (ahead of 92% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$0–$1M
Issuer revenue
Rule 506(b)
Reg D exemption
1
Investors (latest)
2025-01-08
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries A · 2014-06-02 Raised $6.8M (real) Modeled valuation $154M (est)Series A2014Pre-Seed · 2014-06-02 Raised $130K (real) Modeled valuation $4.5M (est)Pre-Seed2014Series A · 2014-06-02 Raised $5.4M (real) Modeled valuation $122M (est)Series A2014Series A · 2014-06-02 Raised $6.3M (real) Modeled valuation $142M (est)Series A2014Pre-Seed · 2014-06-02 Raised $450K (real) Modeled valuation $16M (est)Pre-Seed2014Series A · 2015-07-01 Raised $2.0M (real) Modeled valuation $45M (est)Series A2015Series A · 2015-07-01 Raised $2.0M (real) Modeled valuation $45M (est)Series A2015Series A · 2017-07-01 Raised $6.0M (real) Modeled valuation $135M (est)Series A2017Series B · 2018-08-18 Raised $22M (real) Modeled valuation $545M (est)Series B2018Series B · 2021-01-07 Raised $25M (real) Modeled valuation $524M (est)Series B2021Series B · 2021-01-07 Raised $25M (real) Modeled valuation $524M (est)Series B2021Series B · 2024-09-30 Raised $5.0M (real) Modeled valuation $31M (est)Series B2024Series B · 2025-01-08 Raised $100K (real) Modeled valuation $573K (est)Series B2025Cumulative $106M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$6.8M · 2014
Bridge · Series A-stage$130K · 2014smaller follow-on
Series A extension$5.4M · 2014
Series A extension$6.3M · 2014
Bridge · Series A-stage$450K · 2014smaller follow-on
Series A extension$2.0M · 2015
Series A extension$2.0M · 2015
Series A extension$6.0M · 2017
Series B$22.0M · 2018
Series B extension$25.0M · 2021
Series B extension$25.0M · 2021
Series B extension$5.0M · 2024
Series B extension$100K · 2025

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$573K
Base estimate est.
$235K
Conservative case
$928K
Upside case
$556K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $153.5M · 2014-06-022014Pre-Seed · modeled $4.5M · 2014-06-02Series A · modeled $121.9M · 2014-06-02Series A · modeled $141.7M · 2014-06-02Pre-Seed · modeled $15.5M · 2014-06-02Series A · modeled $45.1M · 2015-07-01Series A · modeled $45.1M · 2015-07-01Series A · modeled $135.4M · 2017-07-01Series B · modeled $545.2M · 2018-08-18Series B · modeled $523.8M · 2021-01-07Series B · modeled $523.8M · 2021-01-07Series B · modeled $31.3M · 2024-09-30Series B · modeled $573K · 2025-01-082025
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.38×/yr
Annual markup
1.67×/yr upside case
1.5 yr
Elapsed time used
1.5 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$5.7M/yr
Capital velocity
12.1 yr
On record since
2014
First round
13
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 14× above median
This company$60.9M
Sector median$4.5M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.0× of median
This company$100K
Sector median$18.3M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$573K
Sector median$33.8M

Raised more than 92% of sector peers (real $). Modeled value above 10% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #55 of 55.

This companyCohort peer
$100K$1.0M$10.0M$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Sevaro Health Inc · Series B Raised $46.0M · modeled $175.0M (est)Field Medical, Inc. · Series B Raised $61.9M · modeled $172.8M (est)Berry Street Health, Inc. · Series B Raised $39.2M · modeled $170.0M (est)Puzzle Medical Devices Inc. · Series B Raised $30.0M · modeled $168.6M (est)Cartwheel Care Inc. · Series B Raised $35.2M · modeled $168.1M (est)Spiro Medical Inc. · Series B Raised $39.1M · modeled $156.6M (est)Nomad Health, Inc. · Series B Raised $106.9M · modeled $153.2M (est)Charta Health, Inc. · Series B Raised $30.1M · modeled $148.8M (est)Integrated Care Partners, Inc. · Series B Raised $55.0M · modeled $145.9M (est)Commons Clinic Inc. · Series B Raised $69.8M · modeled $145.0M (est)Lumata Health Inc. · Series B Raised $35.4M · modeled $131.3M (est)Okami Medical, Inc. · Series B Raised $77.2M · modeled $125.6M (est)Fruit Street Health, P.B.C. (this company) Raised $60.9M · modeled $573K (est)Fruit Street Health, P.B.C.
CompanyStageRaised · realValue · estvs peer med.
Sevaro Health IncSeries B$46.0M$175.0M1.80×
Field Medical, Inc.Series B$61.9M$172.8M1.77×
Berry Street Health, Inc.Series B$39.2M$170.0M1.74×
Puzzle Medical Devices Inc.Series B$30.0M$168.6M1.73×
Cartwheel Care Inc.Series B$35.2M$168.1M1.72×
Spiro Medical Inc.Series B$39.1M$156.6M1.61×
Nomad Health, Inc.Series B$106.9M$153.2M1.57×
Charta Health, Inc.Series B$30.1M$148.8M1.53×
Integrated Care Partners, Inc.Series B$55.0M$145.9M1.50×
Commons Clinic Inc.Series B$69.8M$145.0M1.49×
Lumata Health Inc.Series B$35.4M$131.3M1.35×
Okami Medical, Inc.Series B$77.2M$125.6M1.29×
Fruit Street Health, P.B.C. this companySeries B$60.9M$573K0.01×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$6.8M2014-06-02$30.9M$153.5M90%
Pre-Seed$130K2014-06-02$722K$4.5M85%
Series A$5.4M2014-06-02$24.5M$121.9M85%
Series A$6.3M2014-06-02$28.5M$141.7M90%
Pre-Seed$450K2014-06-02$2.5M$15.5M85%
Series A$2.0M2015-07-01$9.1M$45.1M85%
Series A$2.0M2015-07-01$9.1M$45.1M85%
Series A$6.0M2017-07-01$27.3M$135.4M90%
Series B$22.0M2018-08-18$122.2M$545.2M90%
Series B$25.0M2021-01-07$138.9M$523.8M90%
Series B$25.0M2021-01-07$138.9M$523.8M90%
Series B$5.0M2024-09-30$27.8M$31.3M90%
Series B$100K2025-01-08$556K$573K90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$6.8M2014-06-02
    • First recorded raise — entered as Series A.
    • 190 investors on this round.
  2. Pre-Seed$130K2014-06-02
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 52.3× smaller than the prior — bridge or down round.
    • 4 investors on this round.
  3. Series A$5.4M2014-06-02
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 41.5× larger than the prior — scaling up.
    • 120 investors on this round.
  4. Series A$6.3M2014-06-02
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 175 investors on this round.
  5. Pre-Seed$450K2014-06-02
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 13.9× smaller than the prior — bridge or down round.
    • 12 investors on this round.
  6. Series A$2.0M2015-07-01
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 4.4× larger than the prior — scaling up.
  7. Series A$2.0M2015-07-01
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  8. Series A$6.0M2017-07-01
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 3.0× larger than the prior — scaling up.
    • 190 investors on this round.
  9. Series B$22.0M2018-08-18
    • Raised 14 mo later, in step with the ~14 mo sector norm.
    • Round 3.7× larger than the prior — scaling up.
    • Revenue band moved $0–$1M → $1M–$5M.
    • 420 investors on this round.
  10. Series B$25.0M2021-01-07
    • Raised again after 29 mo — slower than the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  11. Series B$25.0M2021-01-07
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  12. Series B$5.0M2024-09-30
    • Raised again after 45 mo — slower than the ~14 mo sector norm.
    • Round 5.0× smaller than the prior — bridge or down round.
    • Revenue band moved $1M–$5M → $0–$1M.
  13. Series B$100K2025-01-08
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 50.0× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 506(c)).
    • 1 investor on this round.
Intelligence
2025 ~Q4
Modeled next raise · ~11mo cadence
$100K
Modeled next size est.range $100K$160K
0.0×
Last step-up
$5.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Laurence Girard2 other2014-06
Christopher Meatto1 other2014-06
Laurence F Girard1 other2025-01
Asif N Ali2015-07
Frances N Ilozue2015-07
Hatem N Abou-Sayed2015-07
James N Toussaint2015-07
Krishnarao N Tangella2015-07
Laurence N Girard2015-07
Maulik N Purohit2015-07
Omar N Faruk2015-07
Patrick N Tyrance2015-07
Ravi N Kamepalli2015-07
Samir N Bhatt2015-07
Registry & provenance

Fruit Street Health, P.B.C. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1609428
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Brave Care, Inc.HealthtechSeries B$37.5M$930Ksame sector · same stage
Prosperity Health Holdings LLCHealthtechSeries B$18.8M$1.9Msame sector · same stage
Belong Health, Inc.HealthtechSeries C$57.4M$2.6Msame sector
Conavi Medical Corp.HealthtechSeries B$16.2M$2.9Msame sector · same stage
HCSVS Mental Health Telemedicine Startup P.B.C.HealthtechPre-Seed$1.0M$2.9Mnetwork1 shared operator · same sector
New Amsterdam Football Club, P.B.C.OtherPre-Seed$898K$20.7Mnetwork2 shared operators
Imagen Dental Partners, LlcHealthtechSeries A$33.3M$312Ksame sector
Intus Care Inc.HealthtechSeries A$25.2M$1.4Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Berry Street Health, Inc.HealthtechSeries B$170.0M89%
Oak Street Health, LLCHealthtechSeries C$38.4M83%
Orchard Healthcare, Inc.HealthtechSeries B$338.9M83%
City Health Works, Inc.HealthtechSeries A$112.9M81%
Pine Street Healthcare Holdings, LLCHealthtechSeries A$84.7M81%
Carie Health, LLCHealthtechSeed$110.9M80%
binx health LtdHealthtechSeries D+$2.2B79%
CoLabs Medical, Inc.HealthtechSeed$49.4M79%
Frequently asked
How much funding has Fruit Street Health, P.B.C. raised?
Fruit Street Health, P.B.C. has raised approximately $60.9M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Fruit Street Health, P.B.C.'s estimated valuation?
Provath's modeled valuation for Fruit Street Health, P.B.C. is approximately $573K (modeled range $235K–$928K). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Fruit Street Health, P.B.C. at?
Fruit Street Health, P.B.C.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Wed Jan 08.
What does Fruit Street Health, P.B.C. do and where is it based?
Fruit Street Health, P.B.C. operates in the Healthtech sector, based in Fort Worth.
Explore related

See where Fruit Street Health, P.B.C. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Fruit Street Health, P.B.C., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.